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Sepsis is the generalized inflammatory response elicited by
an infectious process [1]. More than 75,000 patients die of
septic shock every year in the USA, making this syndrome
the leading cause of death in noncoronary intensive care
units [2,3]. The respiratory system is the most frequently
affected organ system, and lung dysfunction such as acute
lung injury (ALI) or adult respiratory distress syndrome
(ARDS) is the first step in the development of multiple organ
failure [4e6]. Despite the many advances elucidating the
pathogenesis and treatment of sepsis, no satisfactory
therapy has been developed for ALI/ARDS to date [7].
In Gram-negative bacteria, LPS play a dominant role in
the process of sepsis, and macrophages play an essential
role in inflammation in response to LPS [8]. Macrophages
mediate inflammatory responses by overproducing proin-
flammatory cytokines including interleukin 1b (IL-1b), IL-6,
tumor necrosis factor a (TNFa), and nitric oxide (NO) syn-
thesized by inducible NO synthase (iNOS) [8]. It has been
demonstrated that the induction of heme-oxygenase-1 (HO-
1) expression in RAW264.7 macrophages inhibits LPS-
activated sepsis [9]. Thus, HO-1, as a regulator of inflam-
mation, is considered to be a therapeutic target.
Toona sinensis Roem (TS) or Cedrela sinensis, commonly
known as Chinese mahogany or Chinese Toona, is a perennial
deciduous arbor that belongs to the Meliaceae family
[10,11]. TS is widely distributed over eastern Asia, and TS
leaves have long been used as a vegetable in Taiwan, China,
and Malaysia [12]. Previous pharmacological and bioactivity
studies on the aqueous extract of TS leaves (TSL) have
revealed anticancer [13], antioxidant [14e16], antidiabetes
[17,18], and antivirus [19] activity, improvements in learning
and memory in senescence-accelerated mice [20], and the
reduction of steroidogenesis in mouse Leydig cells [21]. In
addition, no studies have reported significant toxicity from
TSL thus far [12,22]. TSL is also used as Chinese traditional
medicine for the treatment of enteritis, dysentery, and eye
infections [23]. Therefore, TSL might have beneficial effects
on anti-inflammation. This study investigated the anti-
inflammatory activity of TSL against lung injury in a cecal
ligation and puncture (CLP)-induced septic model, and the
macrophage release of NO/iNOS by the induction of LPS.Materials and methods
Preparation of TSL
The TSL, an advanced bioactive fraction, used in this study
was purchased from Taiwan Toona Biotech Corporation
(Kaohsiung, Taiwan), and the TS leaves were obtained from
Tuku (Yunlin County, Taiwan) [24]. The preparation of TSLhas been described in a previous study [24]. Briefly, the TS
leaves were picked and washed with reverse osmosis water.
Reverse osmosis water was then added to the TS leaves at a
proportion of 4 L of water to 1 kg of leaves. The TS leaves
were then boiled for 30 minutes, and the remaining liquid
was concentrated over low heat and filtered with a sieve
(70 mesh). The filtered concentrate was lyophilized with
Virtis (Gardiner, NY, USA) apparatus to obtain a crude
extract. The crude extract was then dissolved in reverse
osmosis water before centrifugation at 1400  g for 12 mi-
nutes, and the supernatant (TSL) was used in all of the
experiments. The extract was further concentrated in a
vacuum freeze dryer to form a powder, and stored at 20C
for subsequent analysis.
In vivo study
Animals
Animal care and experimental procedures were conducted
according to the guidelines for Care and Use of Laboratory
Animals as established by the Kaohsiung Medical University,
Kaohsiung, Taiwan. Prior to the induction of sepsis, adult
male SpragueeDawley rats (250e300 g) were housed in
barrier facilities on a 12-hour light/dark cycle with food and
water ad libitum. The rats were randomly assigned to four
groups: sham-control (saline, sham-operated), TSL (TSL,
sham-operated), CLP (saline, CLP procedure), and TSLþCLP
(TSL and the CLP procedure), n Z 15 in each group. In
brief, oral gavage pretreatment with saline or TSL (1 g/kg/
day) was given for 30 days prior to the CLP or sham pro-
cedure. The dosage of TSL used in this study was according
to the safety evaluation of water extracts of Toona sinensis
Roemor leaves in Dr. Liao’s study [12].
Septic model
Sepsis was induced under anesthesia by CLP modified from
the method of Wichterman et al. [25]. Laparotomy was
performed through a midline abdominal incision. The
cecum was then exposed, ligated with suture, and punc-
tured twice with an 18-gauge needle. The cecum was re-
positioned back into the abdominal cavity and the abdom-
inal incision sutured. The control animals received a sham
procedure that consisted of laparotomy, manipulation of
the cecum, and closure. All of the animals received volume
resuscitation with both intravenous and intraperitoneal
saline (4 mL/100 g of body weight). They were returned to
their cages and allowed free access to food and water.
Histopathological and histochemical assessments of
the lungs
Based upon a previous study that identified 18 hours as the
late-stage of sepsis following CLP [26], rats (3 replicates of 5
TSL inhibits inflammatory responses in sepsis 281animals in each group) were sacrificed at 18 hours post-CLP
or sham operation after being deeply anesthetized with 7%
chloral hydrate (0.4 mL/100 g). Lung tissues were quickly
removed and immersed in the periodate-lysine-2% para-
formaldehyde fixative [27] at 4C overnight. Then samples
were rinsed with phosphate-buffered saline (PBS) and cry-
oprotected in 30% sucrose. Serial frozen sections (5 mm)were
collected on gelatin-coated glass slides and stored at 20C
until use. For each animal, each slide contained six sections
collected at 100 mm intervals throughout the entire tissue
specimen. Two slides were selected for staining with hema-
toxylin and eosin for general cellularity and cell death. Two
additional randomly selected slides were used for isolectin
B4 staining to detect the presence of alveolar macrophages.Figure 1. Effects of TSL treatment on sepsis-associated morta
infiltration in lung tissue. (A) Cumulative survival at 18 hours postsh
(1 g/kg/day for 30 days). Fifteen animals were used in each group.
Lung tissue samples were collected from the rats sacrificed at 18 ho
and eosin (H&E). The arrows show thickened alveolar septa, epithe
airspaces characteristic of alveolar edema in the lung sections ha
images showing the contribution of alveolar macrophages in the lun
staining. Scale bar Z 100 mm. Images are representative of 12 sec
ligation and puncture; TSL Z Toona sinensis leaf extract.This resulted in a total of 12 sections of lung tissue from each
animal for each assessment.
Alveolar macrophages were identified by lectin binding
using the method of Streit and Kreutzberg [28] for specific
binding to the terminal a-galactose on the surface of the
pulmonary macrophage [29,30]. Briefly, sections were
washed in PBS buffer containing CaCl2, MgCl2, MnCl2
(0.1 mM), and Triton X-100 for 20 minutes. The sections
were then bathed in PBS buffer containing peroxidase-
conjugated Griffonia simplicifolia isolectin B4 (0.025 mg/
mL; Sigma-Aldrich, St Louis, MO, USA) at 4C overnight, and
then rinsed in PBS. Sites containing macrophage-bound
peroxidase-lectin conjugates were visualized following 5
minutes of incubation with 3,30-diaminobenzidine (DAB)lity and histopathological changes and alveolar macrophage
am or CLP in rats pretreated with oral gavage with saline or TSL
*p < 0.05, compared with the CLP treatment alone group. (B)
urs after sham or CLP treatment and stained with hematoxylin
lial and interstitial cell infiltration, and narrow or obliterated
rvested 18 hours after the CLP procedure. (C) Histochemical
g tissues. Alveolar macrophages were identified by isolectin B4
tions/animals/stain (n Z 12e15 in each group). CLP Z cecal
Figure 2. TSL inactivated inflammatory responses in LPS-induced RAW264.7 macrophages. (A) The cytotoxic effect of TSL in
RAW264.7 macrophages. Cells were treated with TSL (0 mg/mL, 10 mg/mL, 50 mg/mL, and 100 mg/mL) for 24 hours. MTT assay was
performed to detect viability of the cells and the results were expressed as the absorbance at 570 nm. The results showed that TSL
did not exhibit cytotoxicity in the RAW264.7 cells at concentrations ranging from 10 mg/mL to 100 mg/mL. (B) Effects of TSL on HO-1
expression in RAW264.7 macrophages. Total cell lysates were obtained from cells treated with TSL (10 mg/mL, 50 mg/mL, and
100 mg/mL) for 6 hours and 24 hours. The HO-1 expressions were examined by immunoblotting. Data are expressed as a percentage
of the control values. The bar graph shows the densitometric analysis for three blots from three independent experiments
(mean  standard deviation). b-actin was used as the internal control. The results showed that TSL alone at the concentration of
100 mg/mL significantly induced HO-1 expression after 6 hours and 24 hours of treatment. *p < 0.05 compared with the control
group. (CeF) Pretreatment effects of TSL on inflammatory responses in LPS-induced RAW264.7 macrophages. Cells were pretreated
with TSL (10 mg/mL, 50 mg/mL, and 100 mg/mL) for 30 minutes prior to and during incubation for 24 hours with or without LPS (1 mg/
mL). (C) Nitrite levels in the cultured media were determined by Griess assay and were reflective of NO levels. The results are
presented as mean  standard deviation from five independent experiments in quadruplicate. The results showed that TSL dose-
dependently reduced the nitrite level in LPS-induced RAW264.7 cells compared with the LPS treatment alone group. ***p < 0.001
compared with the LPS-treated group. (D) The iNOS/HO-1 expressions were examined by immunoblotting. Data are expressed as
percentages of the values of the LPS group. The bar graph shows the densitometric analysis for four blots from four independent
experiments (mean  standard deviation). b-actin was used as the internal control. The results showed that TSL (100 mg/mL)
pretreatment significantly reduced LPS-increased iNOS expression and enhanced LPS-increased HO-1 expression. **p < 0.01,
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thionine, dehydrated in ethanol, cleared in xylene, and
mounted in Entellan Neu (Merck, Darmstadt, Germany).
In vitro study
Cell culture
Murine RAW264.7 macrophages were cultured in growth
media [Dulbecco’s modified Eagle’s medium (DMEM; Gibco,
Grand Island, NY, USA) with 10% fetal bovine serum (FBS,
Hyclone, ThermoFisher Scientific, South Logan, UT, USA),
supplemented with 1.5 g/L NaHCO3 and 1% penicillin and
streptomycin (Gibco). Cells were seeded in 24-well plates
or in 35-mm dishes and maintained at 37C in a humidified
environment containing 95% air and 5% CO2. In all experi-
ments, the cells were treated with various concentrations
of TSL for 30 minutes prior to the addition of LPS (Escher-
ichia coli, Serotype 055:B5; Sigma-Aldrich) for the corre-
sponding time points in DMEM with 2% FBS.
Cell viability assay
Cells were cultured in 24-well plates at a density of
2  105 cells/mL and treated with TSL (0e100 mg/mL) at
37C for 6 hours and 24 hours. The stock solution of TSL was
freshly prepared for all of the experiments (1 mg/mL in
double distilled water). 3-4,5-dimethylthiazole-2-yl-2,5-
diphenyl tetrazolium bromide was added to the culture at
a final concentration of 0.5 mg/mL, and the cells were
incubated at 37C for 4 hours. Formazan crystals that
formed in the cells were then solubilized with 500 mL of
dimethylsulfoxide (Sigma-Aldrich) per well, and the absor-
bance at 570 nm was measured using a spectrophotometer
(Beckman Coulter Inc., Fullerton, CA, USA).
NO analysis
NO was evaluated by measuring the amount of nitrite in the
cell culture supernatant using Griess reagent (1% sulphani-
lamide and 0.1% naphthylethylene diamine dihydrochloride
in 5% H3PO4). RAW264.7 cells were pretreated with TSL for
30 minutes, and then with or without LPS (1 mg/mL) for
6 hours and 24 hours. The culture supernatant was
collected and stored at 20C until use. A 100 mL aliquot of
the cell culture supernatant was mixed with 100 mL of
Griess reagent, followed by incubation for 10 minutes at
room temperature. The absorbance at 540 nm was
measured by a microplate reader (MRX ELISA reader;
Dynex, Chantilly, VA, USA) and the inhibitory rates were
calculated using a standard calibration curve prepared from
different concentrations of sodium nitrite.
Measurement of IL-1b and TNF-a
Cells were pretreated with TSL for 30 minutes and then with
or without LPS (1 mg/mL) for 6 hours and 24 hours. A 100 mL***p < 0.001 compared with the LPS treatment alone group. (E, F)
assay after 6 hours and 24 hours of incubation with or without LPS.
five independent experiments in quadruplicate. There were no sig
tween the LPS-treated and TSL þ LPS groups at the same time poi
oxygenase-1; IL-1b Z interleukin 1b; iNOS Z inducible nitric
dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide; NO Z n
sinensis leaf extract.aliquot of the culture supernatant was collected to examine
the levels of the cytokines using an enzyme-linked immu-
nosorbent assay (ELISA) kit according to the manufacturer’s
instructions (eBioscience Inc., San Diego, CA, USA).
Western blot analysis
After the various treatments, cells in 35-mm dishes were
washed with PBS and collected in 50 mL of lysis buffer (0.15%
TritonX-100, 2 mM MgCl2, 25 mM HEPES, 60 mM PIPES, 1 mM
EDTA, 1 mM phenylmethanesulfonyl fluoride, 1 mM sodium
fluoride, 1 mM sodium orthovanadate, 1 mM b-glycer-
ophosphate, 2.5 mM sodium pyrophosphate, 1 mg/mL apro-
tinin, 1 mg/mL pepstatin A, and 1 mg/mL leupeptin, pH 6.9)
and centrifuged at 15,000g at 4C for 30 minutes. Protein
concentrations weremeasured using a protein assay kit (Bio-
Rad Life Sciences, Hercules, CA, USA), and the samples were
stored at70C until further analysis. Protein was applied at
10 mg/lane to 10% sodium dodecyl sulfateepolyacrylamide
gel for electrophoresis, and then transferred to a poly-
vinylidene fluoride membrane. Membrane strips were
blocked for 1 hour at room temperature with 5% non-fat milk
in Tris-buffered saline (150mMNaCl, 50mMTris base, pH 8.2)
containing 0.1% Tween 20, then incubated overnight at 4C
with rabbit anti-heme oxygenase-1 (1:1000 dilution; Stress-
gen, Victoria, BC, Canada), mouse anti-iNOS (1:1000; BD
Transduction Laboratories, Franklin Lakes, NJ, USA), and
mouse anti-b-actin (1:20,000 dilution; Sigma) antibodies, in
Tris-buffered saline-0.1% Tween20 with 5% bovine serum al-
bumin. The strips were then treated with goat anti-rabbit or
anti-mouse immunoglobulin G-horseradish peroxidase-
conjugated secondary antibodies (1:10,000 dilutions; Santa
Cruz Biotechnology, Santa Cruz, CA, USA). The blots were
developed using an enhanced chemiluminescence reagent
(Amersham Biosciences, Piscataway, NJ, USA) and exposed
to Fuji X-ray films. The density of the bands on the poly-
vinylidene fluoride membrane was quantified by densitom-
etry using Gel pro 3.1 (Media Cybernetics, Silver Spring, MD,
USA). iNOS and HO-1 expressions were normalized on the
basis of the b-actin levels. The band intensity of the LPS or
control group was defined as 100%, and the densities of the
bands in the test samples were expressed as a percentage of
the value.
Statistical analysis
All qualitative data are representative of at least three
independent experiments.
ELISA data and survival rates were analyzed by 2  2
analysis of variance (ANOVA), and post hoc analysis
compared by the Bonferroni test. Western blot and nitrite
levels were analyzed by Dunnett’s test. The values were
expressed as mean  standard deviation. A p value <0.05
was considered to be statistically significant.The culture supernatants were collected for TNF-a/IL-1b ELISA
The results are presented as mean  standard deviation from
nificant differences in (E) TNF-a and (F) IL-1b production be-
nt. ELISA enzyme-linked immunosorbent assay; HO-1 Z heme-
oxide synthase; LPS Z lipopolysaccharide; MTT Z 3-[4,5-
itric oxide; TNFa Z tumor necrosis factor a; TSL Z Toona
284 C.-J. Yang et al.Results and discussion
In the present study, we used the CLP model as it closely
resembles the pathophysiology of human sepsis and repre-
sents an indirect insult similar to the pathogenesis of ALI/
ARDS [31e33]. We initially examined whether a survival
advantage after CLP was conferred by TSL pretreatment. As
shown in Fig. 1A, the survival rate of the CLP rats declined
sharply at 18 hours post-CLP (67  7%). More of the CLP rats
pretreated with TSL for 30 days survived at 18 hours during
this period (86  8.6%; tZ 4.63, pZ 0.007). This indicates
that the administration of TSL improved the survival of CLP
rats. Following the histopathological and histochemical as-
sessments in the lungs of the CLP rats with or without TSL
treatment, we also found that TSL pretreatment reduced
CLP-induced lung damage (Fig. 1B). The evidence from he-
matoxylin and eosin staining of the lung sections showed that
CLP-induced septic rats had thickened alveolar septa with
increased inflammatory and interstitial cell infiltration
(Fig. 1B, upper panel) in line with our previous report [26]. In
the CLP rats pretreated with TSL, these histopathological
changes were minimized. Further evidence of inflammatory
and/or immune responses in the lung tissue was provided by
the histochemical images showing the presence of alveolar
macrophages stained by isolectin-B4 (Fig. 1B, lower panel).
Interestingly, we found that daily supplements of TSL in the
rats prior to CLP surgery did not reduce the increased alve-
olar macrophage infiltration. Alveolar macrophages are
regarded as being the most abundant antigen presenting
cells in the airway and alveolar spaces, where they are
critically involved in host defense, both as effector cells that
bind and engulf pathogens and as sentinel cells that secrete
proinflammatory cytokines and chemokines to recruit and
activate inflammatory cells [34,35]. However, it has
been reported that alveolar macrophages may serve to limit
deleterious inflammatory responses within the lungs [36,37].
Taken together, these results suggest that the beneficial role
of TSL in sepsis-induced ALI/ARDS might be related to anti-
inflammatory/immune responses.
To elucidate the possible mechanism by which TSL me-
diates inflammatory signals in sepsis, we used LPS as the
dominant inflammatory response to sepsis in the RAW264.7
macrophage cell line [8]. First, no cytotoxic effects were
observed in 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetra-
zolium bromide (MTT) assays of the RAW264.7 cells treated
with 10e100 mg/mL of TSL for 6 hours and 24 hours (Fig. 2A).
In addition, TSL treatment increased HO-1 protein levels of
the RAW264.7 cells in a concentration- and time-dependent
manner (Fig. 2B) suggesting the antioxidase and anti-
inflammation potential of TSL. Several lines of evidence
have demonstrated that the HO-1 production by monocytes/
leukocytes serves as an anti-inflammatory agent that con-
trols cell or tissue injuries in the presence of oxidative stress
and cytokinemia [9,38]. Therefore, we further detected the
growth and decline of proinflammatory cytokines in the LPS-
induced RAW264.7 cells pretreated with or without TSL. The
concentration of nitrite was determined as NO production
after 24 hours of LPS administration (Fig. 2C). The results
showed that NO production was overproduced to a cytotoxic
level (mM) when the RAW264.7 cells were administered with
LPS alone. Pretreatment with TSL for 30 minutes dose-dependently downregulated NO production and the associ-
ated iNOS protein expression in the LPS-induced RAW
264.7 cells (Fig. 2D). Conversely, a consistent and increased
HO-1 protein expression was observed in the TSL pretreat-
ment groups compared with the LPS treatment alone group
(Fig. 2D). This suggests that the negative correlation be-
tween iNOS and HO-1 protein expression might be due to the
opposite regulation of iNOS and HO-1 in macrophage cells in
response to cytokine exposure and oxidative stress [39].
In the present study, LPS-induced NO production/iNOS
expression in the RAW264.7 cells was prevented by treat-
ment with TSL. Therefore, we hypothesized that pretreat-
ment with TSL may inhibit the production of
proinflammatory cytokines, such as TNF-a or IL-1b, in LPS-
induced RAW264.7 cells. Unexpectedly, TSL did not inhibit
LPS-induced production of TNF-a or IL-1b production in the
RAW264.7 cells (Fig. 2E and F). This indicates that the
specific inhibition of iNOS protein expression and NO pro-
duction and the induction of HO-1 protein might be
responsible for the anti-inflammatory potential of TSL.
Recently, the possibility that TNF-a might be able to
downregulate iNOS expression and decrease infection-
induced lung injury was reported [40]. Clinically, blocking
TNF receptor fusion proteins in patients with septic shock
can worsen patient survival [41]. Therefore, the findings
suggest that the presence of TNF-a in RAW264.7 cells under
LPS and TSL treatment might be beneficial for the anti-
inflammatory effect of TSL. It would therefore be reason-
able to suggest that TSL prevents LPS-induced NO release
and iNOS protein expression in RAW264.7 macrophages
through the negative regulation of TNF-a rather than
through the suppression of TNF-a production [42,43].
In conclusion, the present study provides the first evi-
dence that TSL has the capacity to improve lung injury in
CLP-induced septic rats, and inactivate inflammatory re-
sponses in LPS-induced macrophages. The anti-
inflammatory mechanism of TSL on the inhibition of NO
production and iNOS expression might be through regula-
tion of HO-1 or TNF-a activity. The study provides pre-
liminary data for TSL on CLP-induced sepsis. The beneficial
impact of TSL needs extensive study to get solid evidence.Acknowledgments
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